Ahmed S R, Shalet S M, Beardwell C G, Sutton M L
Br Med J (Clin Res Ed). 1984 Sep 15;289(6446):643-6. doi: 10.1136/bmj.289.6446.643.
Nineteen patients with Cushing's disease were treated with low dose external pituitary irradiation (20 Gy (2000 rad) in eight fractions over 10 days). While awaiting the effects of pituitary irradiation all patients were treated with metyrapone. Seven patients had a complete remission of their disease within six to 12 months of irradiation. They did not require any further treatment and were followed up for a mean of three and a half (range one to eight) years. Another patient had a complete remission after a second course of pituitary irradiation. A further two patients showed a significant biochemical improvement after irradiation, although they were not rendered eucorticoid. There were no complications after this dose of irradiation. These results compare favourably with those reported after pituitary irradiation at conventional doses (40-50 Gy (4000-5000 rad) over four or five weeks) but were not associated with any complications. It is therefore recommended that low dose external pituitary irradiation be used as definitive first line treatment for Cushing's disease.
19例库欣病患者接受了低剂量垂体外部照射(10天内分8次给予20 Gy(2000拉德))。在等待垂体照射效果期间,所有患者均接受了甲吡酮治疗。7例患者在照射后6至12个月内疾病完全缓解。他们无需进一步治疗,平均随访了三年半(范围为1至8年)。另1例患者在第二轮垂体照射后完全缓解。另有2例患者照射后生化指标有显著改善,尽管未达到皮质醇正常水平。该剂量照射后无并发症发生。这些结果与传统剂量(4至5周内给予40 - 50 Gy(4000 - 5000拉德))垂体照射后的报道结果相比更具优势,且未出现任何并发症。因此,建议将低剂量垂体外部照射作为库欣病的确定性一线治疗方法。